FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely infectious diseases. Patient is diagnosed with the presence or absence of hemorrhages, organ dysfunction and hepatomegaly. That is followed by evaluating the level of ASAT, ALT, APTT, INR, prothrombin time, thrombocytes. Estimated time of hospital admission, patient's age, leukocyte count and fibrinogen level. Further, parameters are evaluated in points. Total score is determined. If the total score is more than or equal to 11, a high risk of the lethal outcome of CCHF is predicted. If the total score is less than 11, a low risk of the lethal outcome of CCHF is predicted.
EFFECT: method enables accurate and timely prediction of the risk of the fatal outcome in the CCHF patients at the stage of medical care in first-level or second-level health facilities, optimizing the medical care and prevention of nosocomial infection by evaluating the complex of the most significant indicators.
1 cl, 10 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF HEMORRHAGIC MANIFESTATIONS IN CRIMEAN HEMORRHAGIC FEVER | 2021 |
|
RU2745260C1 |
METHOD FOR PREDICTING RECURRENCE OF ULCERATIVE GASTRODUODENAL BLEEDING | 2021 |
|
RU2774610C1 |
METHOD FOR EVALUATING SEVERITY DEGREE OF A GYNECOLOGICAL DISEASE REQUIRING EMERGENT ABDOMINAL SURGICAL INTERVENTION | 1999 |
|
RU2161308C2 |
METHOD FOR PREDICTING THE RISK OF HEMORRHAGE RELAPSE IN PATIENTS WITH ULCEROUS GASTRIC AND DUODENAL DISEASE | 2006 |
|
RU2318448C1 |
STRAIN OF CULTIVATED HYBRID CELLS OF ANIMAL MUS MUSCULUS L CCHFV Vd-3-PRODUCER OF MONOCLONAL ANTIBODY 3H6/F2 TO VIRUS OF CRIMEAN-CONGO HAEMORRHAGIC FEVER | 2013 |
|
RU2528869C1 |
STRAIN OF CULTIVATED HYBRID ANIMAL CELLS MUS MUSCULUS L CCHFV VD-1-PRODUCER OF MONOCLONAL ANTIBODY 4G/B TO VIRUS OF CRIMEAN-CONGO HEMORRHAGIC FEVER (CCHF) | 2013 |
|
RU2535982C1 |
METHOD FOR ASSESSING THE SEVERITY OF VENTILATOR-ASSOCIATED PNEUMONIA IN CEREBRAL STROKES | 2018 |
|
RU2692957C1 |
STRAIN OF CULTIVATED HYBRID CELLS OF ANIMAL MUS MUSCULUS L CCHFV Vd-2-PRODUCER OF MONOCLONAL ANTIBODY 1E2/E5 TO VIRUS OF CRIMEAN-CONGO HAEMORRHAGIC FEVER | 2013 |
|
RU2528868C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HEMOSTASIS DISPRDERS IN LEPTOSPIROSIS | 2017 |
|
RU2659719C1 |
METHOD FOR PREDICTION OF SEVERE HAEMORRHAGIC FEVER WITH RENAL SYNDROME AT EARLY STAGES OF DISEASE | 2022 |
|
RU2790962C1 |
Authors
Dates
2019-11-19—Published
2019-06-17—Filed